GABELLI FUNDS LLC
Q2 2023 13F-HR Holdings
Net value change ($000)
+458
(0.0%)
New positions
53
Sold out positions
69
Turnover %
5.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CR | 77,175 | NEW |
| IVERIC bio, Inc. | 30,350 | NEW |
| LEN | 28,667 | 22.2% |
| MSFT | 27,044 | 15.0% |
| META | 21,980 | 37.9% |
| AAPL | 21,372 | 16.6% |
| LLY | 21,158 | 67.4% |
| MSGE | 20,787 | NEW |
| AMZN | 19,421 | 26.4% |
| NATIONAL INSTRUMENTS CORP | 18,464 | 236.4% |
Top Reduces (Value $000, Stocks/ETFs)
| CXT | -64,354 | -64.2% |
| Oak Street Health, Inc. | -51,327 | -100.0% |
| INDUS REALTY TRUST, INC. | -36,416 | -100.0% |
| TRAVELCENTERS OF AMERICA INC | -29,660 | -100.0% |
| Maxar Technologies Inc. | -27,025 | -100.0% |
| MONEYGRAM INTERNATIONAL INC | -24,848 | -100.0% |
| FHN | -20,869 | -74.3% |
| ROG | -20,096 | -53.4% |
| SBGI | -19,276 | -100.0% |
| SPHR | -19,220 | -52.4% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|